Nifty
Sensex
:
:
8083.80
27590.95
-170.00 (-2.06%)
-674.36 (-2.39%)

Pharmaceuticals & Drugs

Rating :
61/99

BSE: 500302 | NSE: PEL

912.10
03-Apr-2020
  • Open
  • High
  • Low
  • Previous Close
  •  935.00
  •  936.00
  •  871.25
  •  936.50
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  2422575
  •  21848.12
  •  2666.04
  •  606.85

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 20,579.24
  • 9.41
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 75,684.99
  • 3.00%
  • 0.67

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 46.06%
  • 1.00%
  • 9.95%
  • FII
  • DII
  • Others
  • 29.1%
  • 8.92%
  • 4.97%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.81
  • 20.87
  • 15.83

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 26.42
  • 51.62
  • 15.17

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.12
  • -15.58
  • 2.15

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.12
  • 23.52
  • 17.77

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.52
  • 1.88
  • 2.00

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.25
  • 15.26
  • 13.95

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Net Sales
3,805.67
3,489.30
9.07%
3,603.56
3,144.10
14.61%
3,506.25
2,902.49
20.80%
3,679.67
2,991.06
23.02%
Expenses
1,509.91
1,462.96
3.21%
1,349.69
1,491.06
-9.48%
1,400.43
1,429.85
-2.06%
1,738.03
1,610.27
7.93%
EBITDA
2,295.76
2,026.34
13.30%
2,253.87
1,653.04
36.35%
2,105.82
1,472.64
43.00%
1,941.64
1,380.79
40.62%
EBIDTM
60.32%
58.07%
62.55%
52.58%
60.06%
50.74%
52.77%
46.16%
Other Income
141.33
102.80
37.48%
62.68
56.31
11.31%
66.90
68.46
-2.28%
85.23
36.51
133.44%
Interest
1,441.73
1,169.10
23.32%
1,418.21
1,016.18
39.56%
1,408.49
909.08
54.94%
1,315.65
830.64
58.39%
Depreciation
166.44
132.59
25.53%
166.39
123.36
34.88%
158.21
128.79
22.84%
135.43
115.10
17.66%
PBT
828.92
827.45
0.18%
717.90
569.81
25.99%
594.70
50.98
1,066.54%
562.40
471.56
19.26%
Tax
230.61
293.04
-21.30%
259.92
162.78
59.68%
217.56
181.02
20.19%
224.29
-3,380.01
-
PAT
598.31
534.41
11.96%
457.98
407.03
12.52%
377.14
-130.04
-
338.11
3,851.57
-91.22%
PATM
15.72%
15.32%
12.71%
12.95%
10.76%
-4.48%
9.19%
128.77%
EPS
36.40
32.08
13.47%
27.23
25.95
4.93%
22.14
-3.73
-
24.18
213.61
-88.68%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Net Sales
14,595.15
13,215.34
10,631.03
8,503.65
6,341.51
5,122.61
4,502.74
3,520.19
2,158.87
1,673.08
3,624.47
Net Sales Growth
16.51%
24.31%
25.02%
34.10%
23.79%
13.77%
27.91%
63.06%
29.04%
-53.84%
 
Cost Of Goods Sold
1,649.96
1,529.21
1,518.35
1,401.10
1,305.94
1,314.40
1,195.02
1,113.57
927.24
694.03
1,397.21
Gross Profit
12,945.19
11,686.13
9,112.68
7,102.55
5,035.57
3,808.21
3,307.72
2,406.62
1,231.63
979.05
2,227.26
GP Margin
88.70%
88.43%
85.72%
83.52%
79.41%
74.34%
73.46%
68.37%
57.05%
58.52%
61.45%
Total Expenditure
5,998.06
6,125.28
5,475.73
5,004.50
4,649.26
4,237.69
3,867.83
3,105.38
2,159.80
2,465.72
2,944.25
Power & Fuel Cost
-
113.73
106.48
101.03
98.73
92.15
89.35
82.12
65.82
59.82
79.26
% Of Sales
-
0.86%
1.00%
1.19%
1.56%
1.80%
1.98%
2.33%
3.05%
3.58%
2.19%
Employee Cost
-
2,250.35
1,988.14
1,793.87
1,683.05
1,294.76
1,136.95
796.53
436.42
411.65
573.32
% Of Sales
-
17.03%
18.70%
21.10%
26.54%
25.28%
25.25%
22.63%
20.22%
24.60%
15.82%
Manufacturing Exp.
-
611.25
552.87
506.60
514.80
583.17
557.39
520.26
317.34
145.94
186.33
% Of Sales
-
4.63%
5.20%
5.96%
8.12%
11.38%
12.38%
14.78%
14.70%
8.72%
5.14%
General & Admin Exp.
-
767.65
648.69
628.30
567.54
524.38
473.46
306.39
201.10
202.80
300.12
% Of Sales
-
5.81%
6.10%
7.39%
8.95%
10.24%
10.51%
8.70%
9.32%
12.12%
8.28%
Selling & Distn. Exp.
-
243.71
265.52
280.64
205.77
269.81
245.82
194.24
121.27
110.50
250.27
% Of Sales
-
1.84%
2.50%
3.30%
3.24%
5.27%
5.46%
5.52%
5.62%
6.60%
6.91%
Miscellaneous Exp.
-
609.38
395.68
292.96
273.43
159.02
169.84
92.27
90.61
840.98
250.27
% Of Sales
-
4.61%
3.72%
3.45%
4.31%
3.10%
3.77%
2.62%
4.20%
50.27%
4.35%
EBITDA
8,597.09
7,090.06
5,155.30
3,499.15
1,692.25
884.92
634.91
414.81
-0.93
-792.64
680.22
EBITDA Margin
58.90%
53.65%
48.49%
41.15%
26.69%
17.27%
14.10%
11.78%
-0.04%
-47.38%
18.77%
Other Income
356.14
317.34
264.10
233.75
251.66
254.75
225.43
196.17
472.23
1,317.52
152.92
Interest
5,584.08
4,409.74
2,978.30
2,030.98
974.08
510.60
1,049.58
575.01
215.46
88.83
183.81
Depreciation
626.47
520.15
477.33
381.70
255.45
289.87
246.90
209.56
129.29
95.86
142.65
PBT
2,703.92
2,477.51
1,963.77
1,320.22
714.38
339.20
-436.14
-173.59
126.55
340.19
506.68
Tax
932.38
861.13
-2,876.42
228.12
49.51
344.96
62.75
24.76
5.63
3,679.71
18.03
Tax Rate
34.48%
42.80%
-146.47%
17.41%
6.51%
11.36%
-14.43%
-12.85%
4.66%
22.22%
3.61%
PAT
1,771.54
1,153.71
4,841.40
1,082.43
710.53
2,690.68
-498.28
-223.06
111.50
12,883.36
481.90
PAT before Minority Interest
1,774.39
1,150.74
4,840.19
1,082.14
710.53
2,690.39
-497.52
-217.48
115.26
12,883.67
481.74
Minority Interest
2.85
2.97
1.21
0.29
0.00
0.29
-0.76
-5.58
-3.76
-0.31
0.16
PAT Margin
12.14%
8.73%
45.54%
12.73%
11.20%
52.53%
-11.07%
-6.34%
5.16%
770.04%
13.30%
PAT Growth
-62.01%
-76.17%
347.27%
52.34%
-73.59%
-
-
-
-99.13%
2,573.45%
 
Unadjusted EPS
109.95
74.16
281.75
72.27
52.43
165.20
-29.10
-13.20
6.60
572.20
21.00

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Shareholder's Funds
27,253.03
26,562.39
14,882.57
12,948.35
11,735.93
9,321.06
10,723.56
11,242.03
11,836.42
1,684.89
Share Capital
36.89
36.05
34.51
34.51
34.51
34.51
34.51
34.51
33.58
41.80
Total Reserves
27,211.96
26,526.34
14,848.06
12,913.84
11,701.42
9,286.55
10,689.05
11,207.52
11,802.84
1,643.09
Non-Current Liabilities
29,019.78
25,355.41
18,775.97
11,759.51
7,817.04
6,709.95
1,598.43
1,180.37
1,155.32
1,351.74
Secured Loans
26,182.58
23,420.22
11,714.16
3,099.39
1,539.08
504.42
609.44
208.81
232.25
575.36
Unsecured Loans
837.04
800.39
2,781.53
4,374.61
2,248.40
2,175.18
551.60
439.41
424.30
719.60
Long Term Provisions
5,856.15
5,144.43
4,689.03
4,497.72
4,048.77
4,026.55
346.63
346.81
258.89
0.00
Current Liabilities
31,210.29
22,478.73
18,962.28
10,542.27
5,694.05
9,490.09
11,764.78
6,111.55
4,693.23
1,041.96
Trade Payables
957.25
874.29
764.29
702.56
509.57
485.11
539.18
412.97
339.97
442.50
Other Current Liabilities
14,248.92
6,037.87
5,563.12
2,706.14
1,400.84
1,369.74
1,223.68
764.05
407.35
116.61
Short Term Borrowings
15,578.42
14,665.88
12,079.48
6,828.93
2,829.32
6,400.74
6,018.77
1,014.45
69.32
0.00
Short Term Provisions
425.70
900.69
555.39
304.64
954.32
1,234.50
3,983.15
3,920.08
3,876.59
482.85
Total Liabilities
87,492.13
74,408.53
52,634.03
35,250.25
25,276.13
25,521.10
24,098.57
18,544.29
17,690.73
4,078.59
Net Block
11,196.70
10,725.53
9,972.70
7,525.28
7,065.23
6,191.00
5,709.41
1,827.78
1,443.72
1,977.35
Gross Block
12,618.37
11,782.37
10,552.42
7,779.80
8,876.19
7,671.41
6,889.36
2,489.08
1,903.21
2,753.68
Accumulated Depreciation
1,421.67
1,056.84
579.72
254.52
1,810.96
1,480.41
1,179.95
661.30
459.49
776.33
Non Current Assets
75,088.59
61,842.87
43,470.62
30,595.31
19,911.89
21,149.44
16,397.63
13,307.38
8,036.06
2,145.56
Capital Work in Progress
493.72
647.18
879.63
355.02
277.14
491.07
371.96
260.77
138.45
135.66
Non Current Investment
23,299.47
23,643.62
21,716.66
15,682.30
6,820.88
9,249.93
6,969.82
6,577.86
380.86
32.55
Long Term Loans & Adv.
40,045.44
26,794.43
10,865.75
6,937.04
5,469.79
5,000.80
1,109.37
441.64
269.44
0.00
Other Non Current Assets
53.26
32.11
35.88
95.67
278.85
216.64
2,237.07
4,199.33
5,803.59
0.00
Current Assets
12,403.54
12,565.66
9,163.41
4,654.94
5,364.24
4,371.66
7,700.94
5,236.91
9,654.67
1,933.03
Current Investments
2,447.65
5,198.53
3,463.95
634.40
947.01
195.85
906.94
386.22
1,100.72
0.00
Inventories
835.11
774.02
723.07
723.77
674.94
652.30
541.82
465.60
382.56
469.45
Sundry Debtors
1,406.25
1,355.45
1,107.74
970.81
831.73
719.77
597.57
436.65
374.74
437.61
Cash & Bank
917.51
2,467.01
1,540.90
365.94
460.08
333.60
287.52
57.82
1,770.26
41.18
Other Current Assets
6,797.02
251.88
250.69
155.37
2,450.48
2,470.14
5,367.09
3,890.62
6,026.39
984.79
Short Term Loans & Adv.
6,462.36
2,518.77
2,077.06
1,804.65
2,374.85
1,636.43
4,048.46
3,785.30
4,114.27
976.93
Net Current Assets
-18,806.75
-9,913.07
-9,798.87
-5,887.33
-329.81
-5,118.43
-4,063.84
-874.64
4,961.44
891.07
Total Assets
87,492.13
74,408.53
52,634.03
35,250.25
25,276.13
25,521.10
24,098.57
18,544.29
17,690.73
4,078.59

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
-11,597.46
-15,966.59
-10,056.65
-6,956.19
-2,206.85
-1,604.43
-1,570.46
-684.78
-4,537.14
432.92
PBT
2,434.38
1,963.77
1,310.26
714.38
339.20
-436.14
-173.59
120.89
16,414.55
499.77
Adjustment
1,406.08
1,285.23
812.70
679.55
342.03
1,092.38
632.39
-140.32
-16,451.69
279.28
Changes in Working Capital
-14,561.88
-18,374.37
-11,723.56
-7,977.81
-2,495.18
-2,132.96
-1,880.13
-585.24
-314.67
-231.56
Cash after chg. in Working capital
-10,721.42
-15,125.37
-9,600.60
-6,583.88
-1,813.95
-1,476.72
-1,421.33
-604.67
-351.81
547.49
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-876.04
-841.22
-456.05
-329.63
-344.27
-125.70
-130.00
-74.45
-3,540.60
-107.66
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
-42.68
-48.63
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-826.51
-1,767.73
-2,402.84
-604.04
6,177.07
1,482.91
-1,664.46
-1,581.80
9,157.64
-157.46
Net Fixed Assets
-132.66
-350.07
-713.28
387.94
4.99
-74.35
-89.52
-357.29
614.10
-146.67
Net Investments
711.90
-6,456.37
779.61
-7,831.14
1,363.48
-1,963.06
-2,512.81
-5,527.04
-1,390.60
-62.67
Others
-1,405.75
5,038.71
-2,469.17
6,839.16
4,808.60
3,520.32
937.87
4,302.53
9,934.14
51.88
Cash from Financing Activity
10,752.48
18,650.25
13,570.46
7,543.90
-3,864.63
125.84
3,280.68
640.17
-2,984.62
-313.57
Net Cash Inflow / Outflow
-1,671.49
915.93
1,110.97
-16.33
105.59
4.32
45.76
-1,626.41
1,635.88
-38.11
Opening Cash & Equivalents
2,300.64
1,364.21
226.57
233.35
325.18
268.65
52.98
1,678.88
38.12
94.55
Closing Cash & Equivalent
635.62
2,300.64
1,364.21
226.57
447.01
325.18
268.65
52.98
1,678.88
41.18

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
1442.21
1438.63
837.12
728.33
660.13
524.30
603.18
632.35
684.22
78.24
ROA
1.42%
7.62%
2.46%
2.35%
10.59%
-2.01%
-1.02%
0.64%
118.37%
12.22%
ROE
4.28%
23.36%
7.78%
5.76%
25.55%
-4.96%
-1.98%
1.00%
190.57%
32.10%
ROCE
8.34%
8.52%
8.96%
7.19%
18.70%
3.30%
2.41%
2.60%
213.86%
24.26%
Fixed Asset Turnover
1.08
0.95
0.93
0.77
0.62
0.62
0.76
0.99
0.72
1.37
Receivable days
38.14
42.25
44.38
51.55
54.96
53.08
53.19
67.98
88.00
45.82
Inventory Days
22.22
25.68
30.89
40.00
47.02
48.12
51.81
71.06
92.29
47.24
Payable days
62.95
60.32
59.62
53.66
46.87
53.98
57.39
67.88
92.24
58.77
Cash Conversion Cycle
-2.59
7.62
15.66
37.89
55.11
47.22
47.60
71.16
88.05
34.29
Total Debt/Equity
2.06
1.66
2.05
1.26
0.62
1.02
0.72
0.18
0.06
0.77
Interest Cover
1.46
1.66
1.65
1.78
6.94
0.59
0.66
1.56
187.46
3.72

News Update:


  • Piramal Enterprises receives Rs 6,500 crore on closing sale of DRG business
    2nd Mar 2020, 14:22 PM

    The company would use the money to reduce debt and to explore organic and inorganic growth opportunities

    Read More
  • Piramal Enterprises ranked 1st in India for FY19 Annual Report
    28th Feb 2020, 11:40 AM

    PEL has been ranked 1st globally (Platinum Award) in the ‘Conglomerates’ category, across both print & digital formats

    Read More
  • Piramal Enterprises’ consumer products division signs Sourav Ganguly as brand ambassador
    25th Feb 2020, 11:04 AM

    His association with Polycrol is testament to the company’s legacy brand's strength and trustworthiness

    Read More
  • Piramal Enterprises reports 20% rise in Q3 consolidated net profit
    4th Feb 2020, 12:45 PM

    Total consolidated income of the company increased by 9.88% at Rs 3,947 crore for Q3FY20

    Read More
  • Piramal Enterprises’ PPS planning to expand Aurora facility in Canada
    28th Jan 2020, 11:30 AM

    A total investment of around CAD $25 million will be infused towards this expansion

    Read More
  • Piramal Enterprises’ rights issue over-subscribed around 1.14 times
    23rd Jan 2020, 09:22 AM

    The Rs 3,650 crore Rights Issue offered an opportunity to all its existing shareholders to participate in the capital raise

    Read More
  • Piramal Enterprises raises Rs 300 crore through NCDs
    22nd Jan 2020, 09:36 AM

    The Administrative Committee of Board of Directors of the Company at its meeting held on January 21, 2020 has allotted the same

    Read More
  • Piramal Enterprises’ arm to sell DRG business to Clarivate Analytics
    17th Jan 2020, 14:25 PM

    This divestment is expected to be completed by end of February 2020

    Read More
  • Piramal Enterprises raises Rs 150 crore via NCDs
    17th Jan 2020, 10:26 AM

    The Administrative Committee of the Board of Directors of the Company at its meeting held on January 16, 2020 has allotted the same

    Read More
  • Piramal Enterprises planning to raise Rs 300 crore
    15th Jan 2020, 11:09 AM

    The meeting of the Administrative Committee of the Board of Directors will be held on January 17, 2020, to consider and approve the same

    Read More
  • Piramal Enterprises raises Rs 1,600 crore via NCDs
    31st Dec 2019, 10:27 AM

    The Administrative Committee of the Board of Directors of the company at their meeting held on December 30, 2019, has approved the same

    Read More
  • Piramal Enterprises gets nod to raise funds up to Rs 2,750 crore via bonds
    30th Dec 2019, 10:23 AM

    The money can be raised in one or more tranches from time to time

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.